References
Parkinson-Lawrence EJ, Shandala T, Prodoehl M, Plew R, Borlace GN, Brooks DA (2010) Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda) 25(2):102–115
Anawis MA (2006) Hunter syndrome (MPS II-B): a report of bilateral vitreous floaters and maculopathy. Ophthalmic Genet 27(2):71–72
Kenyon KR (1976) Ocular manifestations and pathology of systemic mucopolysaccharidoses. Birth Defects Orig Artic Ser 12(3):133–153, Review
Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2008) Standard for clinical electroretinography. Doc Ophthalmol 118:69–77
Pitz S, Ogun O, Arash L, Miebach E, Beck M (2009) Does enzyme replacement therapy influence the ocular changes in type VI mucopolysaccharidosis? Graefes Arch Clin Exp Ophthalmol 247(7):975–980
Author information
Authors and Affiliations
Corresponding author
Additional information
Authors have full control of all primary data, and agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data if requested.
Rights and permissions
About this article
Cite this article
Liang, F., Audo, I., Sahel, J.A. et al. Retinal degeneration in mucopolysaccharidose type II. Graefes Arch Clin Exp Ophthalmol 251, 1871–1872 (2013). https://doi.org/10.1007/s00417-012-2215-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-012-2215-1